Technical Analysis for ALTS - ALT5 Sigma Corporation
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.11 | -6.22% | -0.14 |
ALTS closed down 6.22 percent on Friday, November 15, 2024, on 70 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | -6.22% | |
| Bollinger Band Squeeze | Range Contraction | -6.22% | |
| Inside Day | Range Contraction | -6.22% | |
| 50 DMA Support | Bullish | -13.88% |
| Alert | Time |
|---|---|
| 50 DMA Support | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below Lower Bollinger Band | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
Sector: Technology
Industry: Software - Application
Keywords: Disease Pain Opioids Orphan Drug Acute Pain Heroin Morphine Nociception Opioid Use Disorder Peripheral Artery Disease Semisynthetic Opioids
Classification
Sector: Technology
Industry: Software - Application
Keywords: Disease Pain Opioids Orphan Drug Acute Pain Heroin Morphine Nociception Opioid Use Disorder Peripheral Artery Disease Semisynthetic Opioids
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.26 |
| 52 Week Low | 0.35 |
| Average Volume | 175,416 |
| 200-Day Moving Average | 2.38 |
| 50-Day Moving Average | 2.17 |
| 20-Day Moving Average | 2.46 |
| 10-Day Moving Average | 2.37 |
| Average True Range | 0.24 |
| RSI (14) | 41.86 |
| ADX | 16.98 |
| +DI | 18.37 |
| -DI | 20.71 |
| Chandelier Exit (Long, 3 ATRs) | 2.12 |
| Chandelier Exit (Short, 3 ATRs) | 2.72 |
| Upper Bollinger Bands | 2.80 |
| Lower Bollinger Band | 2.13 |
| Percent B (%b) | -0.03 |
| BandWidth | 27.29 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.08 |
| MACD Histogram | -0.0521 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.76 | ||||
| Resistance 3 (R3) | 2.79 | 2.61 | 2.65 | ||
| Resistance 2 (R2) | 2.61 | 2.45 | 2.59 | 2.61 | |
| Resistance 1 (R1) | 2.36 | 2.34 | 2.27 | 2.33 | 2.58 |
| Pivot Point | 2.18 | 2.18 | 2.14 | 2.16 | 2.18 |
| Support 1 (S1) | 1.93 | 2.02 | 1.84 | 1.90 | 1.64 |
| Support 2 (S2) | 1.75 | 1.91 | 1.73 | 1.61 | |
| Support 3 (S3) | 1.50 | 1.75 | 1.57 | ||
| Support 4 (S4) | 1.47 |
